UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota

Not Applicable

Completed

Conditions: Changes in the Oral Microbiota

Interventions: Other: Colostrum

First Posted Date: 2014-12-03

Last Posted Date: 2017-07-25

Lead Sponsor: University of California, Davis

Target Recruit Count: 12

Registration Number: NCT02306980

Locations: 🇺🇸
UC Davis Children's Hospital, Sacramento, California, United States

Undermining During Cutaneous Wound Closure

Not Applicable

Completed

Conditions: Wound Closure Techniques

Interventions: Procedure: Wound Closure with Undermining
Procedure: Wound Closure without Undermining

First Posted Date: 2014-11-13

Last Posted Date: 2017-07-18

Lead Sponsor: University of California, Davis

Target Recruit Count: 50

Registration Number: NCT02289859

Intervention Effects of Intensity and Delivery Style for Toddlers With Autism

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Early Start Denver Model (ESDM)
Behavioral: Early Intensive Behavioral Intervention (EIBI)

First Posted Date: 2014-10-22

Last Posted Date: 2020-01-06

Lead Sponsor: University of California, Davis

Target Recruit Count: 87

Registration Number: NCT02272192

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
UC Davis MIND Institute, Sacramento, California, United States
🇺🇸
University of Washington Autism Center, Seattle, Washington, United States

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Phase 1

Completed

Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Hodgkin Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Refractory Chronic Lymphocytic Leukemia
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Multiple Myeloma
Recurrent Mantle Cell Lymphoma

Interventions: Drug: everolimus
Drug: bendamustine hydrochloride

First Posted Date: 2014-09-16

Last Posted Date: 2019-01-04

Lead Sponsor: University of California, Davis

Target Recruit Count: 20

Registration Number: NCT02240719

Locations: 🇺🇸
University of California Davis, Sacramento, California, United States

Cancer Care Coordination for Chemotherapy Patients

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Mobile Health (mHealth)
Other: No mHealth

First Posted Date: 2014-09-12

Last Posted Date: 2018-11-16

Lead Sponsor: University of California, Davis

Target Recruit Count: 60

Registration Number: NCT02238951

Locations: 🇺🇸
UC Davis Comprehensive Cancer Care Center, Sacramento, California, United States

Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

Phase 2

Recruiting

Conditions: Asplenia

Interventions: Biological: Pneumovax-23

First Posted Date: 2014-09-05

Last Posted Date: 2024-11-29

Lead Sponsor: University of California, Davis

Target Recruit Count: 75

Registration Number: NCT02232191

Locations: 🇺🇸
University of California, Davis Medical Center, Sacramento, California, United States

Delayed Umbilical Cord Clamping - C-section Pilot

Completed

Conditions: Cesarean Sections

First Posted Date: 2014-09-01

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 41

Registration Number: NCT02229162

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Extensive Stage Small Cell Lung Cancer

Interventions: Drug: BKM120
Drug: cisplatin
Drug: etoposide

First Posted Date: 2014-07-18

Last Posted Date: 2018-01-09

Lead Sponsor: University of California, Davis

Target Recruit Count: 3

Registration Number: NCT02194049

Locations: 🇺🇸
University of California at Davis Cancer Center, Sacramento, California, United States

The Lipid Profile of the Skin Surface in Acne

Completed

Conditions: Acne

Interventions: Drug: Tretinoin or Adapalene
Drug: Isotretinoin

First Posted Date: 2014-07-02

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 30

Registration Number: NCT02180425

Locations: 🇺🇸
UC Davis Department of Dermatology, Sacramento, California, United States
🇺🇸
Dermatology Research Area, Davis, California, United States

Performance of Non-Invasive Monitors During ANH

Withdrawn

Conditions: Baseline
Hemodilution

First Posted Date: 2014-07-02

Last Posted Date: 2022-04-27

Lead Sponsor: University of California, Davis

Registration Number: NCT02179827

Locations: 🇺🇸
UC Davis Health System, Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy